Showing results (1761-1770 of 1,777) with videos related to

Sort By:
Pageof 178
World Journal of Pediatrics : WJP|December 9, 2023
Variable phenotypes and outcomes associated with the MMACHC c.482G > A mutation: follow-up in a large CblC disease cohortSheng-Nan Wu, Hui-Shu E, Yue Yu, et al.
Clinical and Translational Medicine|December 27, 2023
The molecular classification of cancer-associated fibroblasts on a pan-cancer single-cell transcriptional atlasBonan Chen, Wai Nok Chan, Fuda Xie, et al.
The Lancet. Digital Health|May 11, 2026
Molecular alterations prediction in gliomas via an interpretable deep learning model: a multicentre and retrospective studyChu Han, Danyi Li, Bingchao Zhao, et al.
Singapore Medical Journal|January 8, 2021
SingHealth Radiology Archives pictorial essay Part 1: cardiovascular, respiratory and neurological casesMark Bangwei Tan, Kim Ping Tan, Joey Chan Yiing Beh, et al.
Singapore Medical Journal|February 23, 2021
SingHealth Radiology Archives pictorial essay Part 2: gastroenterology, musculoskeletal, and obstetrics and gynaecology casesMark Bangwei Tan, Kim Ping Tan, Joey Chan Yiing Beh, et al.
Biosensors & Bioelectronics|December 13, 2021
Discovery and characterization of circulating tumor cell clusters in neuroendocrine tumor patients using nanosubstrate-embedded microchipsNa Sun, Yingying Yang, Hui Miao, et al.
The Journal of Infection|May 29, 2017
An evaluation of purified Salmonella Typhi protein antigens for the serological diagnosis of acute typhoid feverNga Tran Vu Thieu, Tan Trinh Van, Anh Tran Tuan, et al.
The Lancet. Respiratory Medicine|December 15, 2023
Sunvozertinib for patients in China with platinum-pretreated locally advanced or metastatic non-small-cell lung cancer and EGFR exon 20 insertion mutation (WU-KONG6): single-arm, open-label, multicentre, phase 2 trialMengzhao Wang, Yun Fan, Meili Sun, et al.
The Lancet. Oncology|June 16, 2025
Sugemalimab versus placebo, in combination with platinum-based chemotherapy, as first-line treatment of metastatic non-small-cell lung cancer (GEMSTONE-302): 4-year outcomes from a double-blind, randomised, phase 3 trialCaicun Zhou, Ziping Wang, Meili Sun, et al.
Lung Cancer (Amsterdam, Netherlands)|June 28, 2020
A Phase III, randomized, double-blind, placebo-controlled, multicenter study of fruquintinib in Chinese patients with advanced nonsquamous non-small-cell lung cancer - The FALUCA studyShun Lu, Gongyan Chen, Yuping Sun, et al.
Pageof 178